Literature DB >> 11453975

Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient.

I Dalal1, E Grunebaum, A Cohen, C M Roifman.   

Abstract

Purine nucleoside phosphorylase (PNP) deficiency is a rare autosomal recessive disease, which presents clinically as severe combined immunodeficiency (SCID). We report here two novel mutations in the PNP gene that result in SCID phenotype, in a single patient. The maternal-derived allele carries a C to T transition in exon 2 resulting in a premature stop codon at amino acid 57. The paternal-derived mutation is a G to A transition at position +1 in intron 3, causing a complete skipping of exon 3 and a reading frameshift at the exon 2-exon 4 junction. The predicted polypeptide encoded by the aberrantly spliced mRNA terminates prematurely after only 89 amino acids. Both mutations predict severely truncated proteins resulting in a complete deficiency of PNP enzymatic activity, yet the development of profound immunodeficiency in this patient is greatly delayed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453975     DOI: 10.1034/j.1399-0004.2001.590608.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.

Authors:  Ana Toro; Eyal Grunebaum
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

3.  Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency.

Authors:  Raz Somech; Atar Lev; Galia Grisaru-Soen; Shelly I Shiran; Amos J Simon; Eyal Grunebaum
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Purine nucleoside phosphorylase deficiency with fatal course in two sisters.

Authors:  Caner Aytekin; Figen Dogu; Gonul Tanir; Deniz Guloglu; Ines Santisteban; Michael S Hershfield; Aydan Ikinciogullari
Journal:  Eur J Pediatr       Date:  2009-08-06       Impact factor: 3.183

Review 5.  Primary immunodeficiency diseases associated with neurologic manifestations.

Authors:  Soodabeh Fazeli Dehkordy; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2011-10-26       Impact factor: 8.542

6.  Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.

Authors:  Shaiju K Vareed; Vadiraja B Bhat; Christopher Thompson; Vihas T Vasu; Damian Fermin; Hyungwon Choi; Chad J Creighton; Sitaram Gayatri; Ling Lan; Nagireddy Putluri; Gagan Singh Thangjam; Punit Kaur; Mohsen Shabahang; Judith G Giri; Alexey I Nesvizhskii; Alexander A A Asea; Anil G Cashikar; Arundhati Rao; James McLoughlin; Arun Sreekumar
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

7.  The Broad Clinical Spectrum and Transplant Results of PNP Deficiency.

Authors:  Polina Stepensky; Irina Zaidman; Yael Dinur Schejter; Ehud Even-Or; Bella Shadur; Adeeb NaserEddin
Journal:  J Clin Immunol       Date:  2019-11-09       Impact factor: 8.542

8.  The genetic basis of severe combined immunodeficiency and its variants.

Authors:  Diana Tasher; Ilan Dalal
Journal:  Appl Clin Genet       Date:  2012-08-07

9.  Infusion of Sibling Marrow in a Patient with Purine Nucleoside Phosphorylase Deficiency Leads to Split Mixed Donor Chimerism and Normal Immunity.

Authors:  Laura Yeates; Mary A Slatter; Andrew R Gennery
Journal:  Front Pediatr       Date:  2017-06-19       Impact factor: 3.418

10.  Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development.

Authors:  Eyal Grunebaum; Nicholas Campbell; Matilde Leon-Ponte; Xiaobai Xu; Hugo Chapdelaine
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.